Your browser doesn't support javascript.
loading
Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures.
Zhu, Mingsheng; Zhuang, Jie; Li, Zhe; Liu, Qiqi; Zhao, Rongping; Gao, Zhanxia; Midgley, Adam C; Qi, Tianyi; Tian, Jingwei; Zhang, Zhixuan; Kong, Deling; Tian, Jie; Yan, Xiyun; Huang, Xinglu.
Afiliación
  • Zhu M; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Zhuang J; School of Medicine, Nankai University, Tianjin, China.
  • Li Z; School of Cyberspace Science and Technology, University of Science and Technology of China, Hefei, China.
  • Liu Q; CAS Key Laboratory of Molecular Imaging, State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Beijing, China.
  • Zhao R; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Gao Z; School of Medicine, Nankai University, Tianjin, China.
  • Midgley AC; School of Medicine, Nankai University, Tianjin, China.
  • Qi T; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Tian J; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Zhang Z; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Kong D; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Tian J; Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.
  • Yan X; CAS Key Laboratory of Molecular Imaging, State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Beijing, China. tian@ieee.org.
  • Huang X; CAS Engineering Laboratory for Nanozymes, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. yanxy@ibp.ac.cn.
Nat Nanotechnol ; 18(6): 657-666, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36781994
ABSTRACT
The central dogma that nanoparticle delivery to tumours requires enhanced leakiness of vasculatures is a topic of debate. To address this, we propose a single-vessel quantitative analysis method by taking advantage of protein-based nanoprobes and image-segmentation-based machine learning (nano-ISML). Using nano-ISML, >67,000 individual blood vessels from 32 tumour models were quantified, revealing highly heterogenous vascular permeability of protein-based nanoparticles. There was a >13-fold difference in the percentage of high-permeability vessels in different tumours and >100-fold penetration ability in vessels with the highest permeability compared with vessels with the lowest permeability. Our data suggest passive extravasation and transendothelial transport were the dominant mechanisms for high- and low-permeability tumour vessels, respectively. To exemplify the nano-ISML-assisted rational design of nanomedicines, genetically tailored protein nanoparticles with improved transendothelial transport in low-permeability tumours were developed. Our study delineates the heterogeneity of tumour vascular permeability and defines a direction for the rational design of next-generation anticancer nanomedicines.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Nat Nanotechnol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Nat Nanotechnol Año: 2023 Tipo del documento: Article País de afiliación: China
...